A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Isosakuranetin | CAS 26207-61-4 - Request Quote

Picture of Isosakuranetin

Isosakuranetin

SZ CAT No:SZ-N049002
CAS No
26207-61-4
Mol.F.
C16H14O5
Mol.Wt.
286.3
Inv. Status
Synthesis on demand

Chemical Name :

Synonym :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Isosakuranetin is chemically 5,7-Dihydroxy-2-(4-methoxyphenyl)chroman-4-one. It is also known as  4'-Methylnaringenin. Isosakuranetin is supplied with detailed characterization data compliant with regulatory guideline. Isosakuranetin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naringenin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 26207-61-4

Purchase 26207-61-4

Order 26207-61-4

Enquire 26207-61-4

price of 26207-61-4

26207-61-4 Supplier

26207-61-4 Manufacturer

26207-61-4 Exporter

buy high quality Isosakuranetin

Purchase Isosakuranetin

Isosakuranetin suppliers

Isosakuranetin manufacturers

Isosakuranetin price

Order Isosakuranetin

Enquire Isosakuranetin

Isosakuranetin cost

Isosakuranetin Supplier

Isosakuranetin Distributor

Isosakuranetin for Method Validation

Naringenin Reference Standard

Isosakuranetin for ANDA Filing

Isosakuranetin for Forced Degradation Studies

Isosakuranetin Identification Standards

Isosakuranetin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,